Clinical trials
Observational trials in Hong Kong with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
179 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 12 |
| 2018 | 12 |
| 2019 | 22 |
| 2020 | 31 |
| 2021 | 25 |
| 2022 | 28 |
| 2023 | 16 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 179 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 90 |
| The University of Hong Kong | 53 |
| The Hong Kong Polytechnic University | 7 |
| Hong Kong Children's Hospital | 4 |
| Hong Kong Baptist University | 3 |
| Pamela Youde Nethersole Eastern Hospital | 2 |
| Tuen Mun Hospital | 2 |
| Andreas Benesic, MD | 1 |
| Azienda Ospedaliera Universitaria Integrata Verona | 1 |
| Biotronik AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 8 |
| REM Sleep Behavior Disorder | 7 |
| Sleep Apnea, Obstructive | 7 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Colorectal Neoplasms | 4 |
| Crohn Disease | 4 |
| Dementia | 4 |
| Parkinson Disease | 4 |
| Colitis, Ulcerative | 3 |
| Coronavirus Infections | 3 |
Trials
Showing 1 to 25 of 179. Each trial links to its page on Pharma Observatory.
79 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.